HTI
Hikari Tsushin Inc Portfolio holdings
AUM
$1.42B
This Quarter Return
+9.1%
1 Year Return
+16.59%
3 Year Return
+69.38%
5 Year Return
–
10 Year Return
–
AUM
$1.04B
AUM Growth
+$1.04B
(+8.8%)
Cap. Flow
+$1.72M
Cap. Flow
% of AUM
0.17%
Top 10 Holdings %
Top 10 Hldgs %
81.3%
Holding
57
New
–
Increased
4
Reduced
–
Closed
–
Top Buys
| 1 |
Jack Henry & Associates
JKHY
|
$739K |
| 2 |
3M
MMM
|
$370K |
| 3 |
Exxon Mobil
XOM
|
$365K |
| 4 |
Cigna
CI
|
$248K |
Top Sells
No sells this quarter
Sector Composition
| 1 | Financials | 61.07% |
| 2 | Healthcare | 10.15% |
| 3 | Communication Services | 9.46% |
| 4 | Technology | 5.07% |
| 5 | Industrials | 4.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Pfizer
PFE
$141B
| $391K | 0.04% |
10,670
| – | – |
|
52
Huntington Ingalls Industries
HII
$10.6B
| $250K | 0.02% |
1,100
| – | – |
|
53
Fonar
FONR
$101M
| $242K | 0.02% |
14,158
| – | – |
|
54
iShares Biotechnology ETF
IBB
$5.6B
| $174K | 0.02% |
1,373
| – | – |
|
55
Royalty Pharma
RPRX
$15.6B
| $68.2K | 0.01% |
2,220
| – | – |
|
56
Gentex
GNTX
$6.15B
| $59.1K | 0.01% |
2,020
| – | – |
|
57
Organon & Co
OGN
$2.45B
| $12.5K | ﹤0.01% |
599
| – | – |
|